Drugs / Noresthisterone Acetate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00785317 | Nov 2008 → Oct 2009 | — | Karolinska Institutet | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Noresthisterone Acetate | “0.5 mg Noresthisterone Acetate (NETA)on the Postmenopausal Breast; a Double Blind Randomized Prospective Study” NCT00785317 ↗ |
| Known as | NETA | “0.5 mg Noresthisterone Acetate (NETA)on the Postmenopausal Breast; a Double Blind Randomized Prospective Study” NCT00785317 ↗ |
| Route | Oral | “1 mg of oral E2 in continuous combination with 0.5 mg of NETA during six months” NCT00785317 ↗ |